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Abstract In this article, the syntheses and optical proper-
ties of core/shell quantum dot (CdSe/ZnS) and their
applications are reviewed. Nevertheless, the main focus is
to provide an overview on biological applications of
quantum dots that contain imaging, targeting, and sensing.
We discuss the different synthetic methods, optical proper-
ties (photoluminescence intensity, absorption, and fluores-
cence spectra), and their dependence on shape, size, and
inner structure of quantum dots. Also, the different
mechanisms of quantum dots bio-targeting (passive and
active mechanisms) are discussed. The impact of quantum
dots in bioimaging is reviewed regarding its photolumines-
cence intensity, absorption and emission spectrum, and
photo-stability on high-quality and sensitivity imaging.
Further, the difference between near infrared and visible
emission quantum dots in deep tissue imaging will be
reviewed and some of done works are considered and
compared with each other. And finally, the biosensing
potential/application of quantum dots in medical diagnosis
is going to be highlighted.
Keywords Quantum dot (QD) . Photoluminescence
intensity (PL) . Nanoparticles (NP) . FWHM (full width half
maximum) . TEM (transmission electron microscope)
1 Introduction
In nanotechnology area, the “nano” appears to be a prefix
for other sciences/technologies to highlight its integration
with the merged field, in which the operation size range
become an order of nanometer (1–100 nm) at a molecular
level. In fact, due to the big ratio of surface-to-volume and
quantum confinement effects, the most of material proper-
ties (e.g., electronic, optical, chemical, mechanical, and
magnetic) differ from bulk materials when their sizes reach
to nanoscale (Biju et al. 2008; Warburton 2002; Sharma et
al. 2009). Such an approach has significantly promoted
their scientific use in different applications such as military
and optical electronic device (Kershaw et al. 2000; Wang et
al. 2008c) and biological implementations such as bioimag-
ing and biosensing (Ravindran Girija Aswathy et al. 2010;
Debbage and Jaschke 2008; Frasco and Chaniotakis 2009;
Hempen and Karst 2006; Willard et al. 2006), as well as
bio-targeting (Gao et al. 2005; WeiboCai et al. 2007). From
bioimaging and biosensing viewpoints, a nano-scaled
particle can be categorized as an organic dye fluorophores
and inorganic (i.e., semiconductor quantum dot (QD)
(Mazumder et al. 2009) and metallic nanoparticle (NP)
(Klaine et al. 2008; Suchita Kalele et al. 2006). The organic
dyes were used for biological applications even though
their efficiency was not high enough, perhaps due to narrow
absorption spectrum. In fact, for the excitation, a tunable
and fine wavelength of source is essential. The wide
emission spectrum can cause aggregation of nanoparticles
and overlap among different spectra. Moreover, the lack of
photo-stability, photo-bleaching, and the variation of prop-
erties with the alteration of environment are other draw-
backs of organic dyes (Murcia et al. 2008; Yu et al. 2006;
Gao et al. 2005). Most problems associated with the organic
dye fluorophores have been resolved by the emergence of
QDs or NPs. In this article, we focus on QD nanocrystal
with the cadmium selenide (CdSe) core. The wide
absorption spectrum, narrow emission, photo-stability, lack
of photo-bleaching, and high-quantum efficiency have
made these nanostructures very attractive imaging/sensing
materials in comparison with the dye fluorophores. Basi-
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cally, the intensity of fluorescence in imaging and targeting
of biomarkers must be controlled that this can be attained
with manipulating the size and shape of QDs (Jung and Yun
2008). Furthermore, the QDs nanocrystal used in biological
application should be soluble in aqueous solutions thus
various modifications have been imposed to improve the
solubility and safety of QDs. The chemical surface
characteristics dictate the condition of solubility in different
solvents and control its functionalizing, quantum yield, and
blinking (Okuyama and Lenggoro 2004; Dabbousi et al.
1997). Besides, the surfaces chemistry was shown to
influence on hydrodynamic diameter that is one of
fundamental parameters for the application of QD in
diagnostic and therapy approaches (Lees et al. 2008). For
the biological applications of QDs, it is notable to manage
the surface of core with other semiconductor materials with
higher band gap than the core as well as biocompatible
polymer. In most of studies, as shown in Fig. 1, zinc sulfide
(ZnS) has been used to cover the CdSe core. Such coverage
can result to increase quantum confinement effect, photo-
stability, quantum yield, and colloidal stability, while
minimizing the cadmium-based toxicity in in vivo imaging
(Medintz et al. 2005; Vashist et al. 2006; Thurn et al. 2007).
Due to a big surface-to-volume ratio of QDs, they can be
labeled with different biomolecules (e.g., peptide, proteins,
enzymes, antibodies, nucleic acid, oligonucleotides, and
drugs) (Chen et al. 2008; Xing and Rao 2008; Frasco and
Chaniotakis 2010; Wang et al. 2008b) by different
methods. The significant advantages of QDs nanocrystal
in biological application are their simultaneous use in
accurate tumor targeting and high-sensitivity imaging. As
a result, the high performance of imaging and targeting
can be attainable since the small size and narrow
emission of QDs result in a little overlap among their
emission spectrums. In this current article, we review the
revised synthesis methodologies, optical properties, and
bio-impacts of QDs as an imaging/sensing agent for
target therapy of cancer.
Fig. 1 Comparison between organic dyes (rhodamine red/DsRed2)
and inorganic nanocrystal (different size of QDs). a Absorption (Abs)
and emission (Em) of rhodamine red. b Absorption and emission of
six different QD dispersions. c Photo demonstrating the size-tunable
fluorescence properties and spectral range of the ten QD dispersions. d
Nuclear antigens were labeled with QD 630–streptavidin (red), and
microtubules were labeled with AlexaFluor 488 (green) simultaneously
in a 3T3 cell. Bottom row Microtubules were labeled with QD 630–
streptavidin (red) and nuclear antigens were stained green with
Alexa 488. Continuous exposure times in seconds are indicated.
Note the QD resistance to photo-bleaching under continuous
illumination (Medintz et al. 2005)
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The improvement and development of QDs for variation
of application, we must manage the surface of core which
carries out with covering core by other semiconductor
materials with higher band gap than the core. In this article,
we consider the ZnS coverage for the CdSe core of QD
which its impacts result to increasing quantum confinement
effect, photo-stability, quantum yield, colloidal stability,
robust, and minimizing its toxicity in in vivo imaging
(Fig. 2a) are investigated. Due to a big surface-to-volume
ratio of QDs, the different bio-labeling such as DNA and
RNA can be added, in addition to, it can be to link to
biological molecules such as peptide, nucleic acid, oligo-
nucleotides, and antibody (Fig. 2b) by different methods.
The significant advantage of QDs nanocrystal in biological
application is the simultaneous use of them in accurate
tumor targeting and high-sensitivity imaging that the high
performance of imaging and targeting can be attainable
with consideration of small size and narrow emission of
them because of weak overlap between their emission
spectrums.
2 Syntheses and characterization of quantum dots
2.1 Syntheses
In this section, we briefly review the different methods of
syntheses, surface-modified and optical properties. Since
the discovery of quantum confinement effect and big ratio
of surface-to-volume, colloidal semiconductor nanocrystals
have been intensively studied due to their unique size- and
shape-dependent physical properties. The selected nano-
crystal constitutes of core (CdSe) and shell (ZnS) that
separately produce with difference mechanisms dependence
on application. In the growth processing, controlling of
symmetric shape of quantum dots are very important. Since
the growth of nanocrystal is almost uniform, the initial size
distributions depend on time that the core of QD begins to
grow. When CdSe nucleation take place, however, for CdSe
with radii comprised among 1–10 nm, the value of the
capillary length is approaching to particle radius, and the
particle solubility becomes non-linier against “1/r”. There-
fore, the particle growth can be described as diffusion-












In Eq. 1, where dr/dt is the growth rate, K is the constant
proportional to the diffusion constant of the monomer, σ is
the thickness of diffusion layer, and r* is the critical radius
that nanocrystal solubility is exactly dependent the concen-
tration of monomer in solution. This relation shows that
small nanocrystal have the minus rate and dissolve in
solvent, in contrast, the large ones have the positive rate.
When the nanocrystal radius (r) is slightly bigger than r*,
the focus on size distribution can occur and the small
nanocrystal can have swift growth rate than the bigger one
if the monomer concentration remains at high level. With
the depletion of monomers, defocusing (Ostwald ripping;
Jiang 2008; Geissbuhler 2005) can occur that the small
nanocrystals are dissolved and the bigger ones grow. In this
synthetic process, it is very important to control the
precursor rate, proportional injection, solvent symmetry,
size and shape of QDs, and layer passivation which by
accurate appointment of them, we can have the high-quality
syntheses. Overall revision of the different methods of
nanocrystal fabrication is shown in Table 1. But for QD
syntheses, we most use of organometallic technique (Jiang
2008; Yang 2005; Protie’re and Reiss 2006), which this
technique and its sub-methods are illustrated and reviewed
in Fig. 3. In this method, dimethyl cadmimum was
considered as the precursor for the syntheses of high-
quality QD (Hwang and Cho 2005). Anyway, because of
the precursor, this approach is not popular. Therefore, lately,
cadmium oxide (CdO) was reported as a safety precursor
for QD syntheses (Peng and Li 2010) moreover, in this
method, the temperature of interaction is very high
(250–350°C). For attending of this point is very important
which controlling of essential parameters such as QD’s size
and shape, photoluminescence intensity is possible with
managing and regulating of action temperature, molar
Fig. 2 a Typical absorption and
photoluminescence (PL) spectra
of sample CdSe before and after
overcoating with ZnS.
b Schematic of methods for
attaching antibodies and other
proteins to DHLA-capped QDs
(Sapsford et al. 2006)
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proportional, pH, and concentration effects (Jiang 2008;
Geissbuhler 2005; Lu 2005).
Moreover, all the investigators astonishingly follow the
procedure for increasing of quantum yield (proportional of
emission photon to absorbance) and decreasing of number
of QDs in an assay. The atoms in the QD surface can be
defection (decreasing of QY factor) since they have not
fully bonded but most of them eliminate by passivation in
the synthetic method. For the passivation of QD surface, the
use of other material (organic and inorganic) with bigger band
gap than core is suggested and in this tactic, the covering of
QD with inorganic layer is more robust than passivity by
organic ones and higher stability in harsh condition. After the
passivation step, not only most of dangling bond is fixed by
layer but also the pair of electron and hole strictly confined
by the big potential barrier. The varieties of core/shell
nanostructure such as CdSe/ZnS, CdSe/ZnSe, and CdSe/
CdS develop the quantum yields to 85%. Furthermore, one
of the important parameters for the synthetic process is
temperature because in the high temperature, the growth rate
of the core of nanocrystal (CdSe) and following of Ostwald
ripping affected on size distribution and became large but in
low one, incomplete decomposition of precursor can occur
and decrease the crystallizing of coverage layer (ZnS) then
result to have any defect in crystal structure (Herz 2003;
Drbohlavova et al. 2009). The different methods of (CdSe)
QD synthesis and their important selected properties are
shown in Table 2 and moreover, a few difference methods of
CdSe/ZnS production are listed in Fig. 4.
2.2 Optical properties
QDs optical properties (Jiang 2008; Dabbousi et al. 1997;
Xing and Rao 2008) can be studied in the ensemble or single
molecular of physical point view. The observations of single
QDs [and analyzing with TEM (Dabbousi et al. 1997; Guo
et al. 2008) (Fig. 5a)] permit to attain of most noticeable
photo-physical phenomena such as absorption and emission
spectrum, blinking, and other important properties. Any
materials have distinct absorption and emission spectrum for
themselves that can be used to recognize for them. They
produce important data as stoke shift (the fluorescence
emission spectrum is shifted by several nanometer towards
lower energy transition compared to absorptionmaximum that
the important result for that is enormous extending of QDs
size) (Murcia et al. 2008; Machol et al. 1994), inhomoge-
neous broadening, and thermal spectrum. The inhomoge-
neous broadening arises from variety in QDs size and there
is strongly related among electronic structure (Xing and Rao
2008; Schulz 2007), optical properties, and particle size. In
the absorption spectrum, the decreasing of QD size shifts the
onset of it to a visible region due to the increasing of band
gap energy, moreover by alteration of the QD size, its
emission wavelength and color can be adjusted, these
phenomena are illustrated in Fig. 5c, d. The absorption is
sensitive to several chemical and physical influences such as
(Gao et al. 2005; Jiang 2008; Sounderya and Zhang 2008).
1. Spectrum broadening of QDs distribution that arise
from inhomogeneous spread effect, concentration of
crystalline defect, and inhomogeneous environment
2. The absorption spectrum can be affected by QDs’
crystalline structure (FCC, BCC…)
3. The attachment of electrons lead to band flatted related
to first exciton peak (Gotoh et al. 2005) and interband
transmission
4. The covering of QDs surface with inorganic and
organic layer can alter the spectrum absorption.
Temperature as well is a very significant parameter in the
definition of optical characterization of materials that can
impact on absorption and emission spectrums for example,
in the cryogenic temperature (10 K), the spectrum has a
Table 1 Various fabrication techniques for nanostructure materials
(Sharma et al. 2009)














Fig. 3 A few difference
sub-methods of organometallic
technique for CdSe synthesizing
(Geissbuhler 2005)
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sharp characteristic related to wavelength and can compare
with expected of theory, whereas in the room temperature,
we observe a vague of characterization that arises from
thermal broadening (Khoon 2008). Similar to absorption,
the alteration of temperature can influence on emission that
optical feature of it such as FWHM and maximum peak can
be changed. Furthermore, photoluminance (PL) intensity of
QDs strictly depends on temperature fluctuation and their
dependence related to the covering of QD surface. Different
behavior of core and core/shell QDs in the thermal non-
radiative activation theme reflects in PL intensity curve.
These behaviors reveal when QDs used without coverage,
the temperature alteration readily affected on carrier
interaction, transmission, trapping, and other processing
that can arise PL intensity decrement that refers to band gap
increase. But when the core of QDs passivated with another
inorganic layer, the effect of it strictly altered and has
unusual behavior because of the low concentration of defect
and transmission loss (Espinosa 2007). The increment of
PL with increasing of temperature reveals that the non-
radiative rate decreases and this manner of acting remi-
nisced of luminescence temperature anti-quenching. There-
fore, these alterations of features (absorption, emission, and
PL) limit the application of QDs for example, in biological
application of QDs; the influenceable features of QDs must
be controllable for better treatment and therapy (Fu et al.
2005; Vorgelegt 2006; Ted and Chin 2008). Besides, carrier
localization is one of the significant parameters that
severely depend on core and layer shape, size and potential
distribution (Ted and Chin 2008; Burda et al. 2005). The
lately theoretical modeling of CdSe/ZnS QD showed that
the carrier localization is changed with the alteration of core
and shell radius and moreover, it can manipulate the other
optical properties. The covering of core in the QDs is
another effectible parameter in optical properties alteration
such as PL intensity and ref shift. When the core of
nanocrystal cover by inorganic materials with higher band
gap, because of quantum confinement effect (Burda et al.
2005), eliminating of trap, development of dangling bond,
and astonishingly decrease of defect in the surface of core,
the optical characterizations of QDs are improved (Fig. 5b,
c, and d) and is shown in Table 3.
2.3 Surface modification and functionalization
We report most of QDs surface-modified methods that
become water-soluble and functionalized to better interact
with biomolecules as protein and DNA. Nanocrystals
Table 2 Different synthesis (CdSe) methods and their optical and physical properties (Geissbuhler 2005)












1. Cd(Me)2, TOPO 500/580 10–15 25–30 0.2–0.35 Dots 5–10
510/600
2. CdO, 5% TDPA, TOPO 524/555 16–20 30 0.15–0.2 Rods ≥10
540/575
3. CdO, 3% TDPA, TOPO 524/565 9–13 27–30 0.17–0.6 Dots 10
540/575
4. CdO, 3% TDPA, TOPO/HDA 507/543 9–13 26–28 0.4–0.54 Dots 5
520/553
Cd(Me)2 dimethyl cadmimum, TOPO trioctylphosphineoxide, TDPA thiodipropionic acid, HDA 1-hexadecylamine, FWHM full width half
maximum, TEM transmission electron microscope
Fig. 4 A few difference
methods of CdSe/ZnS syntheses
(Geissbuhler 2005; Protie’re and
Reiss 2006)
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become water-soluble if they have polar head group or
charged group at their surface. QDs produced with high
temperature have no water solubility and transferring to an
aqueous solution phase needs to surface functionalizing
with different water solubility methods which surface
functionalizing carry out with ligand exchanging or nano-
crystal capsulation. Many of different ligands can be used
for replacing of QDs surface that have the different benefits
and distinctive applications (Sapsford et al. 2006; Geissbuhler
2005; Medintz et al. 2005). Moreover, most of QD (CdSe,
CdSe/ZnS) syntheses performed in an organic solvent in a
high temperature which comeback to QD with surfactant
covering and the head of surfactant group adds to inorganic
surface that the hydrophobic chain of organic solvent
(toluene and chloroform) bring into QD colloidal stability
but the hydrophobic surface results to insolubility to aqueous
phase. However, because most of QD assays present in an
aqueous phase and need to be a water-soluble particle, the
surfactant layer of QDs should replace or cover with other
layers. It is considerable that the columbic repulsion among
QDs with same polarity prevents aggregation in solvent.
There are several methods for water solubility of QDs, and
this task carries out with different function which one end
interacts with QD surface and other certifies the solubility in
water. The hydrophilic head group used has thiol (−SH) and
carboxyl (−COOH) functionality (Mazumder et al. 2009). In
this article, we revise the several different methods for QDs
water solubility that are illustrated in Fig. 6. Then, the total
tactics for water solubility of QD divides to three categories:
first, the exchanging of cap and consists of replacing of
trioctylphosphineoxide/trioctylphosphine (TOPO/TOP) local
ligand with bifunctional ligand. The second method involves
Fig. 5 a Transmission electron micrograph of QD 522 nm. b
Schematic presentation of absorbance and fluorescence emission
process and trap band in the band gap. c Absorbance and emission
spectra of CdSe. d Absorbance and emission spectra CdSe/ZnS
quantum dots (Lu 2005; Hezinger 2010)
QDs Abs/Emi max (nm) Stoke shift (nm) FWHM (nm) QY Core size (nm)
QD 522 504/522 18 39 0.56 2.7
QD 532 516/532 16 36 0.71 2.74
QD 554 539/554 15 35 0.34 3.31
QD 586 570/786 16 38 0.29 4.41
QD 625 600/625 25 40 0.2 4.66
Table 3 The optical properties
of five different CdSe/ZnS QDs
(Lu 2005)
QDs quantum dots, FWHM full
width half maximum
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constitute of silica layer polymer functionalized with polar
groups that isolate QD surface, and the third procedure
preserves the native TOP/TOPO on the QDs and uses
variants of amphiphilic “diblock” and “triblock” copolymers
and phospholipids to interleave tightly and interdigitate the
alkylphosphine ligands through hydrophobic attraction,
whereas the hydrophilic outer block permits aqueous
dispersion and further derivitization (Chan et al. 2002). The
surface ligand exchange strategy is a direct method for the
replacement of surface hydrophobic ligand with hydrophilic
one such as dihydrolipoic acid (DHLA), mercaptor acetic
acid, and mercaptorsiliane that transforms QDs to water-
soluble state. For example, the DHLA-QD (Tran et al. 2002;
Medintz et al. 2007) has a negative charge and is stable in an
Fig. 6 Distinct methods of QDs solubility (a) insoluble in water, (b) exchange ligand (mercator siliane), (c) exchange ligand (mercator acetic
acid), (d) polymer covering (amphiphilic polymer), and (e) polymer covering (lipid polyethylene glycol)
Nanobio applications of quantum dots in cancer 7
acid solvent (pH>7) afford to the aggregation of QD and
decreasing of PL. The decrement of PL (50–90%) is after
ligand exchange with DHLA because of the reduction of
passivation by DHLA ligand and its effect on trap, dangling
band, and surface charge, and moreover, the diameter size of
that composition gets by AFM (Lee et al. 2007; Eaton et al.
2007) is between 9.9−3.7 and 9.9+3.7 nm. The DHLA-QD
permits the electrostatic adsorption of biomolecules with
positive charge such as avidin or engineering one (poly
histidine tag, maltose-binding protein) which is an important
bio-linker for the attachment of QD to biomolecules such as
protein or DNA on its surface (Eaton et al. 2007; Kim et al.
2004). Nonetheless, drawbacks of the mentioned proce-
dure can limit its application, for example it needs an
engineered protein with positive charge, the covalence
bond of cross-linking because the attitude of DHLA to
protonation is not effective, and in vivo stability and very
low PL are other disadvantages of this procedure. The
second strategy is capsulate and covering of QD with
other layers that transform QDs to a water-soluble state
such as amphiphilic polymer and lipid polyethylene
glycol. Polyethylene glycol phospholipid (PEG-PL) is a
composition that is used in this technique. However, the
dilution of PEG-PLs aqueous brings to spherical micelles
and is a nanometer size and produce possibility for
covering of QD inside polymer.
Due to hydrophobic interaction between TOPO/TOP
ligand and head group of PEG-PLs (Kim et al. 2004; Nie et
al. 2007), the QDs are stable inside micelle hole. The
PEG-PLs in aqueous have low non-specific interaction
and because of nontoxicity, these cannot distort the
protein and other biomolecules. For example, we report
the properties of PEG2000-QD, here, the quantum
efficiency of that remains at 40–80% of non-capsulate
QD. Moreover, the size of functionalized QD of this
procedure due to long chain of PEG2000 is big and
limits its application that the hydrodynamic diameter has
high range (14–24 nm). Another strategy reports the
covering of QD by PLs for eliminating PEG2000-PLs-QD
defect that the advisable advantage of this method is the
decreasing of PLs-QD size and considered for the most
biological application (Jamiesona et al. 2007), and the final
size of QD has ranged between 9 and 12 nm in this
technique. Furthermore, the PLs-QD refine and wash by cut
off concentrator, dialyze but the decrement of PL in this
method is big (22–60% of QD PL), the variation of PL in
abovementioned methods comeback to type, shape, position,
structure, and state of surface ligand and effects of ligand
layer on TOPO/TOP molecule (Lu 2005; Sperling 2008; Xia
and Rao 2009). The comparisons among optical and
electronic properties of methods are illustrated in Fig. 7.
After the solubility of QD, it is ready for attachment of
biomolecules to surface for bio-functionalizing which is
done due to: increment of solubility in water for long time,
the presence of accessible function group for biomolecular
binding, biocompatibility, and decreasing of interfacing
with native organic nanoparticles. Applying of QD to
biological system, the special biomolecule adds to QD
surface without optical property devastation which attaches
to QDs by a cross-linker with hydrophilic surfactant layer
by active group such as –NH2, –COOH, or –SH
(Mazumder et al. 2009; Medintz et al. 2007). Attaching
carried out by different techniques including direct linkage,
covalent linkage, and electrostatic interaction (Huh et al.
2005) is illustrated in Fig. 8.
At the first method, the biomolecules consist of a thiol
group that can be linked to QD surface by mercapto-
exchanging process but the cross-linker between Zn and
thiol is not tight and dangled, therefore they easily
dissociate of QD surface and result to the aggregation of
it. Moreover, small molecules such as oligonucleotides,
deferent serum albumin readily adsorb to QD surface that it
depends on pH (Gao et al. 2002), temperature, and surface
charge. In the second method, many scientists demonstrated
the technique for the attachment of protein to QD surface
with electrostatic interaction that considered an engineered
protein (maltose-binding protein; Tran et al. 2002; Zhao et
al. 2008) with positive charge to reveal electrostatic interac-
tion with negative charge on DHLA-QD surface but is not
sufficiently specific and introduces biological milieu. More-
over, the functionalized QD is not suitable for in vivo
application due to the interference of protein with other
positive charges, low QY, and the application of DHLA-QD in
a specific environment. The last procedure (covalent linkage)
displays a very stable binding between QD and biomolecules
with the use of a bio-linker and this method is too used for QD
functionalizing for in vivo application such as labeling and
imaging. Because most of water solubility methods bring out
the covering of QD such as carboxylic acid, amino, or thiol
group, QDs easily linked to a functional group and can be
used for distinctive application. Therefore, the use of QDs in
biological application strictly depends on bio-linker and
biomolecules that the difference of a cross-linker such
as 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide usu-
ally used for binding of –NH2 and –COOH and SMCC
(4-(N-maleimidomethyl)-cyclohexanecarboxylic acid N-
hydroxysuccinimideester) used for –SH and –NH2, by
using the third method, the distinction of biomolecules
such as biotin, peptide, and protein including streptavidin,
avidin, albumin, and antibody is possible to conjugate
nanoparticles with ligands, peptides, carbohydrates,
nucleic acid, protein, lipids, and polymers (Sapsford et
al. 2006; Geissbuhler 2005; Sperling 2008; Xia and Rao
2009; Mulder et al. 2006; Rhyner et al. 2006; Yu et al.
2007a, b; Smith and Nie 2004; Aihua Fu et al. 2005). But
there are some distinctive procedures for surface changing
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of QD that are summarized in Fig. 9, and biomolecule
attached and their applications are listed in Table 4.
3 Nano-biological applications
Human cancer is a complex disease that is brought by
unstable genes and alteration of multiple aggregative
molecules. The customary diagnostic and beforehand of
cancer cannot give complete details of cancer location,
therefore the traditional methods for cancer diagnosis such
as medical imaging and tissue biopsy have low efficiency
and sensitivity, and most of cancer antigen agents cannot
differentiate between cancerous and normal cells which
become toxic and result to normal cell death. Besides,
cancer is often recognized late, and we only detect the
cancerous site when its size reach 1 cm in diameter and the
cancerous cell has metastasized into other parts of body
which in this stage, controlling and destroying them are not
attainable, for example the breast and prostate cancer.
Because of those reasons, human cancer is identified as a
deadly disease. For solving the problem and selecting the
method for complete destruction of the cancerous cells, we
need systems that do three important tasks: (a) accurate
detection and sensing, (b) tune targeting and obvious
imaging, and (c) fine delivery of a drug. With consideration
to the above cases, only functionalized QDs with astonish-
ing properties can explain cancer disease and in this section
of article, we review and report the three important
characteristics of QDs as sensing, targeting, and imaging
which are done in a different institute and laboratory (Nie et
al. 2007; Smith et al. 2006; Corlu et al. 2007). With regard
to QD application in a biological field, we can divide into
three categories: biosensing (DNA, protein, and sugar
sensing and immunoassays), bio-targeting (passive and
active), and bioimaging (live cells, in vitro, single mole-
cule, and in vivo imaging) (Drbohlavova et al. 2009; Xia
and Rao 2009). Therefore, QDs are the best candidates for
Fig. 7 Normalized PL spectra
comparison of two QD samples




(e) non-PEG-PLs-QD, (b) AFM
image of DHLA-QD625 on
Mg2+-modified mica, (d) TEM
images of PEG2000-PLs
encapsulated QDs with emission
at 586 nm, (f) TEM images of
PLs-QDs with emission at
586 nm. (Lu 2005)
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biological application because of their optical and physical
properties (the big absorption cross-section, broaden ab-
sorption spectra, narrow emission spectra, high-quantum
efficiency, resistance to photo-bleaching, photo-stablity,
brightness, and the tunable of peak of emission wavelength)
and the big volume-to-surface ratio that causes to attach of
most biological molecule to QDs surface and the methods
of QDs functionalized are explained and revised in Section
2.3 and most of the QD functions that are reviewed are
listed in Table 4. Then, in the following of sensitive
methods for the detection and diagnostic of cancer,
nanotechnology is identified as a big promise which their
Fig. 8 Common methods used for the QD biofunctionization
including: (a) direct linkage to the TOPO-coated QDs [biomolecules
can be linked including thiolated DNA (ligand exchange)] or peptides
with adhesive domains, (b) electrostatic interaction, and (c) covalent
linking (Xing and Rao 2008)
10 A. SalmanOgli
unique properties enable contrast and detectives in order of
10–100 magnitude, then of traditional biomarker in bio-
imaging and blood assay. The heart of this technology lies
in ability for the decreasing of device size and the
construction of nano device in the range between bimolecules
and atoms.
3.1 Nano-biosensing applications
The biosensors are a novel class of developed probes that
are used for biomarker detection in the real-time form, and
the many applications of biosensors relate to DNA, protein,
and sugar sensing and immunoassays which the biosensors
can be significant for the diagnosis of cancer site due to
high operation rate, easy use, low price, and the surprising
enabling in high selection rate of biomarkers. The QDs are
ideal for biosensing application because of their resistance
in photo-bleaching and real-time performance. The func-
tionalized QDs can be used in the base of fluorescence
resonance energy transfer (FRET is a process in which
energy is transferred by a non-radiative, long-range dipole–
dipole coupling from fluorophores in an excited state
serving as a donor to another proximal ground state
acceptor) mechanism that elucidates the ligand receptor
binding and the alteration of molecular structure. In the
FRET mechanism, QDs play donor role and acceptors can
be the dye molecules; in this system, the distance between a
donor and an acceptor is a 1–10-nm scale and QDs offer
several advantages when used as a donor in FRET system
such as tunable size and narrow emission spectra which
noticeably decrease the overlapping among adjacent spec-
tra, and moreover expand absorption spectra allow to select
an excitation source that relates to minimum absorption of
an acceptor and decreasing of direct excitation. Several
studies reveal the effective use of QD-FRET for the
detection of an analyte by using traditional strategy that
implies to binding of QD to target acceptor such as
proteins, antibody, or DNA aptamer (Sapsford et al. 2006;
Kim et al. 2004; Tran et al. 2002; Basabe-Desmonts et al.
2007). By implementation of the FRET mechanism, the
labeled targets lie in the near of QDs and cause to saturate
the PL of QD for a limited number of acceptors, therefore
the presentation of target to the FRET system brings about
decreasing of quantum efficiency and continually increase
of QD’s PL then with those alteration, therefore, we can
sense the multiple important target including the sensing
and detecting of different analyte as nutrient maltose and
explosive TNT. Moreover, in the FRETsystems, as depicted
in Fig. 10a, the rate of energy transfer depends on the
overlap of fluorescence spectrum of the donor and
absorption spectrum of the acceptor, quantum yield of the
donor, relative orientation of the donor and acceptor
transition dipoles, and the distance between the donor and
the acceptor. This allows to measure: (a) interaction among
molecules, for example proteins or a protein and a ligand
and (b) distances between two sites in a macromolecule.
Overall, the important parameters that control the FRET
systems are excited-state life time, medium refractive index,
Fig. 9 Schematic illustration resuming the different bioconjugation
methods. a Use of a bifunctional ligand such as mercaptoacetic acid for
covalent linkage of NCs to biomolecules. b TOPO-capped NCsbound
to a modified acrylic acid polymer by hydrophobic interaction. Then,
biomolecules are covalently attached. c NC solubilization and bio-
conjugation by exchanging TOPO against mercaptosilane, additional
silanization and finally covalent linkage to a biomolecule. d Creation of
negatively charged NCs through ligand exchange, then adsorption of
biomolecule via electrostatic interactions. e Incorporation of NCs
intonanobeads, then linkage to biomolecules (Geissbuhler 2005)
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quantum yield of donor, relative orientation of donor–
acceptor dipole, integration of spectrum overlap between
the donor and the acceptor, and the number of acceptors
attached at each QD. In this section, we report several
examples of QD biosensing applications: (a) Goldman and
coworkers used of QDs conjugated to an antibody for small
molecular detection. (b) QDs are used in monitoring of
protein biomarkers in stationary cells including the meas-
urements of antigen cells B and Twith different colors and
proliferation monitor in PMP70. (c) Hahn et al. revealed
that the improvement of QDs’ sensitivity compare to dye
organic for detection of Escherichia coli 0157:H7. (d) The
use of sandwich immunoassays for simultaneous detection
of four toxins cholera, ricin, shiga-like toxin 1, and
staphylococcal enterotoxin B is reported. (e) Another
example displayed the use of QD-antibody for the sensing
of difference between diphtheria and tetanus toxins. (f)
Yang et al. showed the concurrent detection of bacteria and
Salmonella typhimurium by the use of QDs’ different
colors. (g) The use of QD probes in fluorescence in situ
hybridization for the detection of DNA and mRNA is
reported. (h) Panthak et al. report the labeling of Y
chromosome in human sperm cells employed by QD-
oligonucleotide probes. (i) Xiao and coworkers used QD–
streptavidin at labeling of special probes biotinylated
oligonucleotides for HER2 localization. (j) Moreover, the
QD-FRET used for DNA detection is reported. (k) Chen
and Gerion observed that the viral peptides called nuclear
localization signals conjugated with CdSe/ZnS QDs has no
toxic effect in HeLa cells transfected with the peptide-
coated QDs and shown in Fig. 10b (Geissbuhler 2005;
Drbohlavova et al. 2009; Medintz et al. 2007; Peng and Li
2010; Smith et al. 2006).
For conclusion, the mention of this point is noticeable
that FRET measurements enable to convey the important
data from donor–acceptor interaction. However, there are
Table 4 QDs biomolecule attached and their application
QD–functions Applications Ref.
QD–RGD peptide Labeling and imaging (Mazumder et al. 2009)
QD–streptavidin Immunolabeling (Mazumder et al. 2009)
QD–AFP-Ab Imaging and targeting (Chen et al. 2008)
QD–oligonucleotides Cell labeling (Sapsford et al. 2006)
QD–streptavidin/biotinylated DNA FISH detection (Sapsford et al. 2006)
QD–DNA Hepatitis B and C and SND detection and biosensing (Sapsford et al. 2006; Medintz et al. 2005)
QD–avidin Labeling (Sapsford et al. 2006)
QD–anti-TNT Immunodetection (Sapsford et al. 2006)
QD–antibody Biosensing and small molecular detection (Sapsford et al. 2006)
QD–aptamer ATP detection (Drbohlavova et al. 2009)
QD–protein Biosensing (Smith et al. 2006)
QD–MBP-Cy3-β-CD-Cy3.5 Biosensing (Toshihide and Kayozabo 1992)
QD–TAT Endothelial cell targeting and labeling (Stroh et al. 2005)
CHP–QD–Hela Cervical cancer (Wang et al. 2008a)
QD–Luc8 BRET system (Xia and Rao 2009)
QD–PSMA Prostate cancer (Fu et al. 2005)
QD–PEG–PLA Biomedical imaging and detection (Manda et al. 2005)
QD–PEG–antibody Prostate cancer detection (Jamiesona et al. 2007)
QD–PEG–DSPE Magnetic imaging (Mulder et al. 2006)
QD–peptide In vivo vascular tumor targeting (Fu et al. 2005)
QD–CA 125 Ovarian cancer (Peng and Li 2010)
QD–HER2 Breast cancer (Peng and Li 2010)
QD–PSA Prostate cancer (Peng and Li 2010)
QD–anti-claudin-4 Pancreatic cancer (Peng and Li 2010)
QD–AFP HCC (hepatocelluar) (Peng and Li 2010)
QD quantum dot, AFP alpha-fetoprotein, PSA prostate-specific antigen, MBP maltose-binding protein, FISH fluorescence in situ hybridization,
PSMA prostate-specific membrane antigen, HER2 human epidermal growth factor receptor 2, CA 125 carbohydrate antigen 125, PEG
polyethylene glycol, DSPE 1,2 distearoyl-sn-glycero-3-phosphatidylethanolamine, PLA polycaprolactone, Luc 8 luciferase, RGD arginine–
glycine–aspartic acid, DNA deoxyribonucleic acid, BRET bioluminescence resonance energy transfer, ATP adenosine triphosphate
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several problems that can disrupt the FRET systems
operation including: (a) the QDs that bring out of the same
synthetic method have different structure and spectra
because of more stage of QD synthesizing and small
fluctuation for defect present in core and layer. These
defects have a significant effect on photo-physical proper-
ties of QD, peak situation of spectra distribution, and
spectra median of QDs that affected on Förster radius of
FRET system. (b) Another annoying parameter that can
affect on FRET parameters is blinking. The QD blinking is
associated to charge trapping and un-trapping at surface
defects during excitation and results in alternation (at all
timescales) of bright and dark states during which no
photons are emitted. For the last case, we must mention that
QDs have a longer life time (20–30 ns) than dye
fluorophores (1–4 ns) and auto-fluorescence (2 ns). Be-
cause the fluorescence decay of QDs is long enough, the
auto-fluorescence signal (is one of the noise source and
reason for decreasing of FRET system sensitivity) has
vanished and QDs still emit photons (Stroh et al. 2005).
3.2 Nano-bio-targeting impacts
The cancer stem cells are the set of cells that contain the
self-reproducible properties. Lately, the therapy of cancer
may be very effective if the stem of cancer cells are fine
targeted and this task need for a device similar to molecule
and atom size that can easily move and have unique
properties to satisfy the tune-targeting parameters such as
tunable size, photo-stability, resistance to photo-bleaching,
and robust (Juzenas et al. 2008; Meijering et al. 2006) was
hypothesized. By reviewing several reports, we reveal that
most of cancer antigen agents cannot differentiate between
normal and cancerous cells and cause to be toxic of them;
therefore, nanotechnology offers some distinctive methods
for targeting and can produce significant advantage for
cancer patient therapy. In fact, the use of nanoparticles for
targeting is an important application of nanotechnology in
cancer that proposes two methods for that: passive and
active targeting.
3.2.1 Passive targeting
The cancerous tissues include two arrogant factors because of
them. The QDs easily accumulate and aggregate in tumor
site. The factors necessary for passive targeting are: (a) the
growth of tumor site produces vascular endothelial growth
agent to promote the angiogenesis. (b) Most of tumor sites
lack lymphatic drainage systems which cause to accumulate
QDs to targeted location. For passive targeting, the size and
surface properties of nanoparticle must be controlled,
therefore for the improvement of targeting time, the optimum
size of QDs should be smaller than 100 nm in diameter and
the surface of QDs must be amphiphilic. In this targeting
strategy, the normal tissues are connected by endothelial cells
and QDs cannot pervade into cells but the tumor cells have
most leakage site and cause to penetrate QDs into vascular
cells. However, in some cancers such as lung, passive
targeting is an inefficient method because in this cancer,
tumor site accessibility is very hard and this method is not
used (Sharma et al. 2009; Yu et al. 2007b). The scheme of
passive targeting method is illustrated in Fig. 11a.
Fig. 10 FRET mechanism. a Energy diagram for the non-radiative
energy transfer. S0(D) and S1(D) are the ground and first excited
singlet states of the donor; kD and kD/A are the rate constants for the
radiative and non-radiative energy transfer processes, respectively.
Solid lines depict photon-participated transitions; dashed lines depict
resonant transitions in the electronic structures of the donor and
acceptor. b Further utility of QDs have been found in labeling of
nucleus in live cells, however, this issue has not been not fully studied.
(Geissbuhler 2005; Drbohlavova et al. 2009)
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3.2.2 Active targeting
The active targeting is usually attained by binding of QDs
to targeting element that produces superiority accumulation
of QDs in tumor organs, tumor, cancer cells, or interstitial
tumor cells. This procedure is in the base of especial
interaction as antibody–antigen, ligand–receptor, and lec-
tin–carbohydrate. In this method, because the use of
attached particle in QDs surface, the targeting character-
istics such as efficiency and speed are high. The targeting
proposition is one of the significant problems in cancer
therapy in which the precision and high-speed performance
targeting are affected on accurate diagnostics of tumor site
and decreasing normal cell destruction. The scheme of
active targeting of tumor site is illustrated in Fig. 11b.
In the in vivo state, the QD probes can be delivered to
tumor site both by passive targeting mechanism and active
targeting. In the passive targeting, big molecule and particle
accumulate in tumor area with preference regarding through
permeability development and retain effect but active
targeting use of specific antibody attached to QD surface
for targeting the considered point. For example, when QD-
anti-AFP for targeting was used, we can reveal the obvious
fluorescence of an area and then easily analyze data, but in
the passive targeting mode, a few of QDs can be reach to a
target point and we have no obvious targeting, therefore this
distinction between the targeting methods and QDs or QD-
anti-AFP fluorescence are illustrated in Fig. 12a, b, and c.
Moreover, when the QDs targeted the tumor and accumu-
late in that area, we can arrange contour map of
fluorescence intensity of QDs in the cancerous tumor. The
contour map (Fig. 12d) is a fluorescence intensity map that
organizes by the measurements of intensity detected site by
site. The different colors in the map show the inhomoge-
neous distribution of cancer cells in the targeted point. The
cold colors display the low intensity of fluorescence which
is because of low population of QDs in tumor site and vice
versa the hot color. Therefore, the numbers of QDs arrived
to tumor site perfectly depend on the targeting method and
if we used active targeting, most of injected QDs can be
reach to a cancerous tumor and we have a very bright
contour map. Furthermore, the map shows the complexity
of tumor site (Gao et al. 2004; Yu et al. 2007a, b).
3.3 Nano-bioimaging implementations
The nanoparticles have optical properties that make them
suitable for high-quality imaging and in this category of
application, the nanoparticle specifically QDs are used as
fluorescence marker of live cell receptors and depended
marker to oncologic. The QDs absorb white light and re-
emit that in few nanoseconds which have tunable wave-
length dependent on size, semiconductor natures, and the
proportional composition of material used in structure
which spreads the wavelength between UV to infrared
(IR) (Kairemo et al. 2008; Ballou et al. 2004). In the past
years, several techniques are used for imaging and imply to
signal that emits from tissue by the use of an ultrasound
wave, X-ray wave, gamma rays, and radio wave and the
contrast of image (the most of different tumor is identified
in the base of image contrast) produced by the difference of
attenuation of signals which usually are function of tissue
and anatomy structures. However, none of attained image
can totally analyze the cancerous tumor site that may do
with quantitative in vitro assay and tissue biopsy evalua-
tion, besides the multiple detection of biomarker becomes
very hard by the use of those traditional techniques and
none of them have no possibility of an inherent high-spatial
resolution of small tumor site. As a result, the production of
highly accurate spatial image of low population of
biomarker can astonishingly trend to detection and diag-
nosing of cancer and especially for metastases sites (Willard
Fig. 11 a Permeation and
retention of QD probes via
leaky tumor vasculatures
(passive targeting). b High
affinity binding of QD–antibody
conjugates to tumor antigens
(active targeting)
(Gao et al. 2004)
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et al. 2006; Sperling 2008). With the introduction of the
above important point, because QDs have the photo-
stability greater than organic dye, this unique property
allows them to construct high-rate imaging and 3D image
with high resolution. Moreover, resistance to photo-
bleaching became very important, if the assay for detection
and imaging of live cell alteration needs a very long time in
order of days or weeks. In contrast to dye fluorophores,
QDs have wide photon absorption spectra and narrow
emission tunable spectra that the simultaneous detection
and imaging of multiple targets become possible. Recently,
the novel QDs are presented that have expanded absorption
spectra (UV-IR), therefore the multicolor imaging of targets
is attained and reached images are easily analyzed with
important details (Peng and Li 2010; Pinaud et al. 2006). In
this section, we only review the in vivo imaging. The
unique optical properties of QDs cause them to be a very
attractive device as the fluorophores in the in vivo imaging,
whereas the customary fluorescence in the base of an
organic molecule produces slight stability and small
possibility in simultaneous detection of multiple targets
(Sounderya and Zhang 2008; Medintz et al. 2005; Sperling
2008; Xia and Rao 2009; Jaiswal et al. 2004). Therefore, in
contrast with traditional in vivo imaging probes such as
positron emission tomography, single photon emission
computed tomography, and MRI (Zhao et al. 2008; Mulder
et al. 2006), QDs antibody labeled and targeted produce
several features and unique capabilities: (a) optical and
electronic properties depended on size and are tunable with
particle size alteration which produces the expand range of
nanoparticle for simultaneous detection and imaging of
cancerous cell biomarkers. (b) The QDs have big surface-
to-volume ratio to accumulate several different functional
groups that can use to diagnose multiple targets, therefore
this condition obligates to design of multifunctional nano-
particles for high-quality imaging. (c) The wide researches
Fig. 12 Histological examination of QD passive and active targeting
ability. a Passive targeting. b Active targeting c Fluorescence spectral
comparison between QDs and QDs-anti-AFP. d Fluorescence intensity
contour map of a detected cancerous area in the QDs-tagged tumor.
Although all the sampling sites are in the tumor, their fluorescence
intensities are different and the map exhibits the inhomogeneous
distribution of the fluorescence intensities in the detected area of the
tumor; (Yu et al. 2007a, b)
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have been shown that the nanoparticle in size (10–100 nm)
without antibody attached aggregated in tumor site because
of permeability and retention reasons (Nie et al. 2007).
Furthermore, the high brightness of QDs and its resistance
to photo-bleaching enable them to continually emit for a
long time present them as important agent for in vivo
imaging, as well as in nanoparticle syntheses improvement,
covering and surface modification significantly enhanced
them application in targeting and imaging. With the use of a
suitable cover, we can attain long exposure time, high
stability, and decreasing of QDs depositing that are very
important in vivo parameters. One of the important
properties of QDs is the big absorption cross-section that
enables them for more efficient performance of deep tissue
specimen by multi-photon excitement. With the use of this
technique, the fluorescence signals can be detected in depth
of several microns through live mice at an in vivo imaging.
For example, the results of NIE groups showed that the
potential use of QDs for design of remote particle in
targeting and in vivo imaging of live animals. Another
report shows the use of QDs conjugated to specific
antibody for labeling on cancerous prostate cells (PSMA).
As a result of QDs properties (big absorption cross-section,
long life time, and photo-stability), in vivo imaging
constructed by QD agents is very sensitive and blithe but,
auto-fluorescence emitted from substrate (noise) are a
caution for this procedure and can be an important
limitation factor. For elimination of this factor, more
strategy is suggested: (a) one method is an emission
scanning microscopy that is used for separation of
fluorescence emission of QDs and auto-fluorescence be-
cause of narrow emission of QDs. (b) The effective method
is a spectral displacement visible to near infrared (NIR)
because most of the chromosphere organs absorb slight
light in high wavelength and another profit of this method
is used in deep tissue imaging (Jamiesona et al. 2007; Fu et
Fig. 13 a In vivo targeting and imaging subcutaneous tumor model
with QD–AFP–Ab probes the spectra analysis of the tumor site (red
arrow) and the normal tissue adjacent to the tumor site (green arrow).
The fluorescence spectra of tumor site were the same with those of
QD–AFP–Ab probes, but there was no characteristic 590-nm peak of
the QD at the normal tissue site. b The HE staining of the tumor
section. c The confocal microscopic imaging of the tumor section
showed the specific binding of QD–AFP–Ab probes to tumor cells. e,
f, g The QD distribution in the liver, spleen, and kidneys. The tissue
sections were observed with CLSFM. As shown in the figures, QD590
was mainly distributed in the liver, spleen, and kidneys (Chen et al.
2008)
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al. 2005). Tissue imaging with NIR and IR excitation
eliminate some of visible imaging problems such as slight
transfer of visible light through depth tissue. Because in the
NIR window spectrum, the Rayleigh scattering is de-
creased, besides the absorption due to water and hemoglo-
bin has the minimum quantity. Moreover, there is small
amount of dye molecule that emits light between NIR, then
background noise significantly decreased (Rhyner et al.
2006; Smith and Nie 2004; Smith et al. 2006; Zhao et al.
2008; Lim et al. 2003; SalmanOgli and Rostami 2010). One
of the in vivo assays report showed the use of QDs
conjugated to AFP-Ab for in vivo imaging and histological
examination of QD and QD-AFP-Ab are shown in Fig. 11.
Nonetheless, diagnostic of small metastases site is a very
important case in cancer which in above example the QD-
AFP-Ab is injected to live mice for lung metastases
imaging. In this assay, the spectral analyses reveal that
normal organ fluorescence spectra is similar to cancerous
one but has not the intensity peak and moreover, specific
binding probes to metastases confirm by Fig. 13 and their
reports display the QD-AFP-Ab probes can be used to
detects of small lung metastases and HCC lung metastases
model (Chen et al. 2008; Yu et al. 2007a, b). Another report
of an in vivo cancer detection explains the specific
conjugation of QD to anti-AFP binding to hepatoma and
they use QD anti-AFP for AFP that is the original element
of mammalian fetal serum and the alteration of AFP blood
level determines the hepatocelluar carcinoma, therefore the
aggregation and retention of AFP in the tumor site are
essential for detection and imaging for cancer therapy (Yu et
al. 2007a, b). In the next assays of in vivo imaging and
targeting, the use of surface ligand PEG with QDs is
reported that used for performance time improvement,
decreasing of dosage, and targeting development (Manda
et al. 2005; Stroh et al. 2005; Zhao et al. 2008). Recently,
the self-illuminating QDs conjugated to new probes for in
vivo imaging are reported.
4 Conclusion
In this article, we revised the distinct methods of syntheses,
optical properties and surface modification and functional-
ization of QDs (CdSe/ZnS) for specific biomedical appli-
cations such as detecting and sensing and targeting and
imaging. With regard to late reports and assays, we revealed
that: (a) the different methods of syntheses significantly
affected on optical properties (peek absorption distribution,
FWHM of emission spectra, and coordination of absorption
and emission spectra), physical properties (size, inhomoge-
neity of QDs structure), (b) the distinct functionalized
procedures carry out by attention to specific application and
the QDs size must be controlled, (c) the functionalized
particle must be confirmed by considering some vital
parameters such as photo-stability, photo-bleaching, bio-
compatibility, and non-toxicity, (d) the separate composition
of functionalized QDs can be used in FRET mechanism for
biosensing application, (e) the active targeting is an
effective method which performed with high speed and
accurate targeting and easily used for cancerous site
targeting, (f) imaging with QDs functionalized is done for
high resolution and precision and attained imaging disclose
the small cancerous site with majority details that help me
for cancer therapy.
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